Healthcare and Medicine
- Overview
-
In 2022, the size of China’s health and medical markets exceeded RMB 10.5 trillion, an increase of RMB 1.3 trillion compared with the previous year and a like-for-like growth of 14.6%. The markets are growing and expected to go over RMB 15 trillion by 2026.Currently, the global biopharmaceutical industry is showing a clustered development that is mostly concentrated in countries and regions such as the U.S., Europe, Japan, India, Singapore and China. China’s biopharmaceutical industry only emerged in the 80s; albeit relatively late, the development was rapid with strong demand for legal services.As a first-rate general law firm, Globe-Law has gathered together leading figures renowned in their respective practice areas. Our team has extensive experience in the health and medical industries and is able to provide all-round services in pharmaceutical supervision, investment and financing and intellectual property protection.
- Services
-
Our services for healthcare and medicine include but are not limited to:
- Pharmaceutical supervision
- Prevention of legal risks for pharmaceutical companies
- Building of compliance systems
- Competition and antitrust matters
- Intellectual property protection, including drug research and development, patent arrangements and technology transfer
- Dispute resolution
- Investment and mergers and acquisitions
- Retaining corporate legal counsel
Outstanding and influential attorneys in China offering all-round and high-quality professional legal services that greatly satisfy client demands.